搜尋結果
New Hope For Hereditary Deafness: Latest Results
Forbes· 9 小時前Approximately 430 million people live with disabling hearing loss, and 26 million individuals ...
Amylyx to buy bankrupt Eiger's experimental drug to treat low blood sugar
Reuters· 16 小時前Amylyx Pharmaceuticals has agreed to buy the rights to bankrupt drugmaker Eiger ...
Argenx’s Vyvgart Shot Gains US Approval for Rare Nerve Disorder
Bloomberg· 17 小時前Argenx SE’s Vyvgart Hytrulo shot gained US approval to treat a rare nervous system disorder, a ...
US FDA approves Roche's drug for a chronic blood disorder
Reuters· 17 小時前, opens new tab drug for a chronic blood disorder, the Swiss drugmaker said. The drug ...
Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of ...
CNBC· 18 小時前Eli Lilly on Friday said it applied for U.S. approval of its weight loss drug Zepbound for the ...
Pitch Deck Teardown: Feel Therapeutics' $3.5M seed deck
TechCrunch· 21 小時前Feel Therapeutics is working to make mental health care more science-forward. The company makes wearable devices, mobile ...
Council Post: The Evolution Of AI And Mental Healthcare
Forbes· 1 日前People have been using chatbots for decades, well before ChatGPT was released. One of the first chatbots was created in ...
Social media fueling suicide epidemic in US
China Daily· 1 日前In times of disinformation, deep fakes and artificial intelligence that have further blurred the lines between reality and ...
Stronger health awareness awakens sleep economy
China Daily· 2 日前China's sleep economy is experiencing rapid growth as well as showing vast business potential, thanks to a consumption upgrade ...
This little-known biotech stock is primed to surge nearly 50%, Canaccord says
CNBC· 2 日前Analyst Sumant Kulkarni said the catalyst for projected growth was the company's ...